Management holds a conference call to discuss Phase 2b HARMONY Week 96 Data on March 4 at 8 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AKRO:
- Akero Therapeutics price target raised to $43 from $40 at H.C. Wainwright
- Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Akero Therapeutics reports Q4 EPS (99c), consensus (86c)
- Madrigal opportunity in MASH remains after Boehringer data, says UBS
- Cantor biotech/biopharma analysts to hold analyst/industry conference call